Singapore markets closed

Eupraxia Pharmaceuticals Inc. (EPRX.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
6.97-0.17 (-2.38%)
At close: 03:59PM EST
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-33,354
-23,259
-22,990
-3,997
Depreciation & amortisation
202.832
193.273
111.529
116.809
Stock-based compensation
2,546
2,020
4,215
228.68
Change in working capital
2,058
2,073
-211.431
1,583
Other working capital
-25,209
-19,085
-15,073
-403.784
Other non-cash items
1,328
1,160
3,409
1,797
Net cash provided by operating activities
-25,092
-18,776
-14,642
-403.784
Cash flows from investing activities
Investments in property, plant and equipment
-117.411
-308.37
-431.673
-
Purchases of investments
18,000
0
-9,000
-
Sales/maturities of investments
0
9,009
0
-
Other investing activities
-
-
-5,018
-56.687
Net cash used for investing activities
17,883
8,701
-14,450
24.618
Cash flows from financing activities
Debt repayment
-193.211
-185.182
-586.426
-1,101
Common stock issued
21,529
13,298
37,833
0
Other financing activities
-
-
-
-235.949
Net cash used provided by (used for) financing activities
28,670
13,523
49,915
-626.644
Net change in cash
21,460
3,447
20,824
-1,006
Cash at beginning of period
11,804
20,892
150.126
1,156
Cash at end of period
33,264
24,736
20,892
150.126
Free cash flow
Operating cash flow
-25,092
-18,776
-14,642
-403.784
Capital expenditure
-117.411
-308.37
-431.673
-
Free cash flow
-25,209
-19,085
-15,073
-403.784